Skip to content

Clinical trials

Completed Carcinoma, Transitional Cell trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Transitional Cell Status: Completed Country / region: United Kingdom Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20121
20132
20152
20165
20173
20182
20194
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb2
British Urology Researchers in Surgical Training2
Eli Lilly and Company2
Hoffmann-La Roche2
Incyte Corporation2
Nektar Therapeutics2
Basilea Pharmaceutica1
Bayer1
Daiichi Sankyo1
Dr Anjali Zarkar1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Transitional Cell22
Urinary Bladder Neoplasms13
Carcinoma, Non-Small-Cell Lung4
Neoplasm Metastasis4
Acrocephalosyndactylia2
Breast Neoplasms2
Carcinoma, Renal Cell2
Colorectal Neoplasms2
Melanoma2
Neoplasms2

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.